Human V-Set Domain Containing T-Cell Activation Inhibitor 1,VTCN1 ELISA Kit

Contact us for 48 wells and bulk quote

Introducing the HUMAN V-SET DOMAIN CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1 ELISA KIT, a cutting-edge solution designed to facilitate accurate and efficient detection of VTCN1 protein levels in human samples. This advanced ELISA kit is meticulously crafted to cater to the needs of researchers and clinicians alike, enabling them to delve into the intricate mechanisms of T-cell activation inhibition.

The HUMAN V-SET DOMAIN CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1 ELISA KIT boasts a comprehensive set of components, meticulously curated to ensure optimal performance and reliability. With its high sensitivity and specificity, this kit empowers users to quantitatively measure VTCN1 protein levels with utmost precision, thereby facilitating insightful investigations into the role of T-cell activation inhibition in various physiological and pathological processes.

Featuring a user-friendly protocol, the HUMAN V-SET DOMAIN CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1 ELISA KIT streamlines experimental procedures, minimizing the likelihood of errors and maximizing efficiency. Its robust design and meticulous manufacturing process guarantee consistent and reproducible results, enabling researchers to confidently draw meaningful conclusions from their experiments.

The HUMAN V-SET DOMAIN CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1 ELISA KIT is meticulously validated and optimized to ensure exceptional performance across a wide range of human samples. Its versatility allows for the analysis of various sample types, including serum, plasma, and cell culture supernatants, thereby accommodating diverse research needs.

In summary, the HUMAN V-SET DOMAIN CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1 ELISA KIT represents a state-of-the-art solution for the accurate and efficient detection of VTCN1 protein levels. With its unrivaled sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to unravel the intricate mechanisms underlying T-cell activation inhibition, paving the way for groundbreaking discoveries in the field of immunology.